Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes
Launched by UNIVERSITY OF COLORADO, DENVER · Feb 13, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
A total of 170 participants were initially enrolled in the comprehensive behavioral weight loss intervention.In this study, investigators will conduct a follow-up visit 3 years after the completion of the intervention. Only participants who completed the behavioral weight loss intervention will be enrolled in this study. Participants will undergo testing of body weight, body composition, physical activity patterns, energy intake patterns, sleep patterns, resting metabolic rate, and total daily energy expenditure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)
- • Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)
- • Capable and willing to give informed consent
- • Possess a smartphone to install and utilize the meal timing application
- • Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days
- • Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes
- Exclusion Criteria:
- • Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)
- • New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)
- • Women who became pregnant after completing the Parent Trial
- • Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Seth A Creasy, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials